{
    "type": "ETF",
    "ucits": true,
    "replication_method": "synthetic",
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication using swaps",
        "Counterparty risk exposure",
        "Complex index tracking"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication via an over-the-counter swap contract with counterparties like Morgan Stanley and Societe Generale, which introduces counterparty risk. While the swap is used for index tracking rather than leverage or inverse exposure, the presence of derivatives and counterparty risk makes this a complex product under MiFID II. The MSCI China index itself includes A-shares, H-shares, and other complex equity exposures, adding to the complexity. The fact that the swap is unfunded (as implied by the lack of collateral management discussion) further supports the complex classification. The PRIIPs KID and factsheet confirm the synthetic replication and counterparty risk, with no indication that the derivatives are used solely for efficient portfolio management (EPM). The risk profile includes derivative-specific risks like leverage risk and valuation risk, which are not easily understood by retail investors.",
    "confidence": 90
}